首页> 中文期刊> 《中国医院用药评价与分析》 >3种磺脲类药用于2型糖尿病初始治疗的疗效与短期经济学评价

3种磺脲类药用于2型糖尿病初始治疗的疗效与短期经济学评价

         

摘要

目的:探讨3种磺脲类药用于2型糖尿病初始治疗的短期经济学效果。方法:选取2012年8月—2015年8月牡丹江医学院红旗医院收治的2型糖尿病患者180例作为研究对象,以随机数字表法分为格列美脲组、格列喹酮组和格列吡嗪组,每组各60例。格列美脲组患者给予格列美脲4 mg,1日1次;格列喹酮组患者给予格列喹酮15 mg,1日3次;格列吡嗪组患者给予格列吡嗪15 mg,1日1次。12周为1个疗程,治疗过程中检测血糖及糖化血红蛋白( HbA1 c)。结果:格列美脲组患者的总有效率显著高于格列吡嗪组,格列美脲组患者餐后2 h血糖下降百分率、HbA1 c下降率均显著高于格列喹酮组、格列吡嗪组,差异均有统计学意义( P<0.05);将评价指标设定为餐后2 h血糖下降百分率,格列美脲组、格列喹酮组比格列吡嗪组分别增加了8.44、17.54元;将评价指标设定为HbA1 c下降率,格列美脲组、格列喹酮组比格列吡嗪组分别增加了36.49、53.96元;餐后2 h血糖下降百分率、HbA1 c下降率均不敏感于药品价格;3组患者的不良反应发生率之间的差异均无统计学意义( P>0.05)。结论:格列美脲较格列喹酮与格列吡嗪初治2型糖尿病短期经济学效果好。%OBJECTIVE:To probe into the short-term economic effects of 3 kinds of sulfonylurea drugs in the initial treatment of type II diabetes .METHODS: 180 patients with type II diabetes admitted into Hongqi Hospital of Mudanjiang Medical University from Aug .2012 to Aug .2015 were selected to be divided into glimepiride group , gliquidone group and glipizide group via the random number table , with 60 cases in each .Patients in glimepiride group were treated with glimepiride 4 mg, once a day;the gliquidone group were given gliquidone 15 mg, 3 times a day;and the glipizide group received glenn pyrazine 15 mg, once a day; 12 weeks for a treatment course .And the blood glucose , HbA1 c were determined during the treatment process .RESULTS:The total effective rate of glimepiride group was was significantly higher than that of glipizide group;the decent percentage of blood glucose after 2 h and HbA1 c of glimepiride group were significantly higher than those of gliquidone group and glipizide group , with statistically significant difference ( P 0.05).CONCLUSIONS:The short-term economics effects of glimepiride is better than gliquidone and glipizide in the initial treatment of type 2 diabetes.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号